Carrot Fertility, Inc.

Carrot Fertility, Inc. is a global fertility and family-building benefits provider that partners with employers, health plans, and health systems to offer comprehensive support for employees worldwide. The company's mission is to provide accessible fertility care and family-building support for everyone, everywhere, covering the spectrum from maternity through menopause and pre-pregnancy through parenting. Carrot Fertility emphasizes expanding access and improving outcomes through compassionate, personalized, and inclusive support. The company operates with a fully distributed team across numerous states and countries, reflecting its global reach and modern workforce structure.

Carrot Fertility's platform offers a wide array of services, including egg, sperm, and embryo freezing; assisted reproduction such as IVF and IUI; gestational surrogacy; and adoption support. Additionally, it provides care for pregnancy and postpartum, parenting and return-to-work, and hormonal health. Key offerings include the Carrot Card, which simplifies payments and eliminates reimbursement hassles, and the Carrot Rx program, designed to provide cost savings on fertility medications. The company's personalized plans guide members to a global network of over 17,000 providers in more than 195 countries.

Under the leadership of Founder and CEO Tammy Sun and Co-Founder and Chief Medical Officer Dr. Asima Ahmad, Carrot Fertility maintains a strong market position as a leading global fertility and family care platform. Recent developments include the March 2026 presentation of new metabolic-fertility care research at the HHS National Conference on Women's Health, showcasing their AI-powered "Sprints" program for preconception metabolic optimization. In January 2026, the company expanded its flexible plan design with a new cycle-based fertility option, and in August 2025, it significantly grew its nationwide network of high-performance clinics. Carrot Fertility also partnered with Cigna's Global Health Benefits unit in March 2025 to enhance fertility offerings.

Latest updates

Carrot Fertility Integrates Pelvic Floor Therapy, Targeting $3,000 Savings Per Patient

  • Carrot Fertility partnered with Origin, a pelvic floor therapy provider, to integrate services into Carrot's existing fertility and family care platform.
  • The partnership provides Carrot members with access to virtual and in-person pelvic floor therapy, along with Origin's digital programs.
  • Origin claims the integrated therapy can reduce costs by over $3,000 per patient annually.
  • An internal Carrot survey indicates 85% of Carrot members report symptoms related to pelvic floor health.
  • Origin is in-network for over 50 million people and accepts Medicare.

Carrot's partnership with Origin signifies a broader trend toward expanding fertility and family care benefits to encompass preventative and specialized women's health services. This move addresses a significant gap in employer-sponsored healthcare, as pelvic floor dysfunction is often undertreated and costly. By integrating Origin's services, Carrot aims to improve member outcomes, reduce healthcare costs, and solidify its position as a leading platform in a rapidly evolving market.

Financial Impact
The $3,000 per patient savings claim requires validation; Carrot will need to demonstrate tangible ROI for plan sponsors to drive adoption and justify the partnership's cost.
Market Adoption
Widespread integration of pelvic floor therapy into employer benefits packages will depend on overcoming existing stigma and educating both employers and employees about the value proposition.
Competitive Response
Other fertility and family care platforms will likely evaluate similar partnerships to address the growing demand for comprehensive women’s health services, potentially intensifying competition in the space.
CID: 1945